Day: November 20, 2024

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programs Platform will focus on first and best-in-class drug discovery and development, demonstrating the ability to find novel insights and dramatically reduce the time and cost of discovery

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Elanco Animal Health Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELAN

NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Elanco Animal Health Incorporated (NYSE: ELAN) between November 7, 2023 and June 26, 2024, both dates inclusive (the “Class Period”), of the important December 6, 2024 lead

New Shares Issued to Stakeholders of EFG Hermes Pakistan Limited

Karachi: In a significant development within the financial sector, EFG Hermes Pakistan Limited has issued new shares to the shareholders of Intermarket Securities Limited as part of a court-sanctioned scheme of arrangement. This move has resulted in a…